Method for producing an aqueous solution hydroxylamine

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Domo Caproleuna Gmbh patent solves the following problem:

Special safety conditions must comply with the publication of HA as heat weakness is one of its assets, ie it decomposes in a bone, especially in the presence of metal ion, the strongly alkaline media, and high temperature and concentration. The heat composition of HA causes irreversible losses and reduces product yield.

Our analysis of this patent is as follows:

Domo Caproleuna Gmbh’s patent US 7425247 B2 deals with Method for producing an aqueous solution hydroxylamine.
This invention relates to a method for the production of an aqueous solution of free hydroxylamine (HA) simultaneous countercurrent treatment of a HA salt with ammonia or ammonia water, then divide the HA by distillation and reconcentrating the aqueous HA solution in a countercurrent with a stripping medium. The stripping medium used according to the invention is a mixture of steam and a non-condensable inert gas and the process temperature to a defined pressure to control the number of non-condensable inert gas inlet column. The non-condensable inert gas is nitrogen. This results in increased safety and a reduced loss in the procedures for bringing the aqueous solution of free HA.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Matrix-forming composition containing pectin

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The N.V. Nutricia patent solves the following problem:

Obesity is a major health problem with approximately ninety-seven million people considered clinically overweight in the United States.

Our analysis of this patent is as follows:

N.V. Nutricia’s patent US 7422764 B2 deals with Matrix-forming composition containing pectin.
A liquid food composition with a pH greater than 6, a viscosity below 600 MPAs in a shear rate of 100s-1 and 20 C., and a viscosity of at least at least 125% of the aforementioned viscosity at a pH below 5 and a temperature of 37 C., the composition comprises at least 0.05 wt. % Pectin having a degree of methoxylation between 2 and 50 and / or alginate; at least 5 mg calcium per 100 ml; and at least 0.1 wt. % Indigestible oligosaccharide having a degree of polymerisation between 2 and 60. Another aspect of the invention relates to a method for the treatment or prevention of overweight or obese mammals, the method comprising enteral administration to a mammal an effective amount of the aforementioned composition.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Radiation crosslinking of halogen-free flame retardant polymer

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Sabic Innovative Plastics Ip B.V. patent solves the following problem:

Crosslinked polyamide compositions known in the art (See, W. Feng et al., Radiation Physics and Chemistry, 63, pp. 493-496 (2002)). Japanese published application 59-012936A2 describes a crosslinked polyamide resins that obtained by exposing a polyamide resin containing a crosslinker of a radiation beam. resin will be free glass fiber, and a flame retardant or filler can be incorporated into the resin.

Our analysis of this patent is as follows:

Sabic Innovative Plastics Ip B.V.’s patent US 7423080 B2 deals with Radiation crosslinking of halogen-free flame retardant polymer.
Cross-linking, flame retardant polymer composition which containing a polyamide or polyester; a flame retardant system; and a crosslinking agent.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nucleic acid and protein homologs and uses thereof

File for Quick & Easy Patent Protection with PowerPatent.

The Abt Holding Company patent solves the following problem:

Gene is the basic unit of information that is inherited in an organism and so many mechanisms available to ensure the stability of their ranks over many generations. These strengthen mechanisms to ensure that the order of the nucleotides that contain a gene to stay in a constant form during, and since this nucleotide sequences encoding the regulatory sequence is to determine gene expression and coding sequences that determine protein structure and function of these genetic properties also stably maintained. following the race that the gene can be distinguished based on differences in their ranks. The gene sequences to determine the expression pattern and function of the gene and the protein product, thus gene with a different order are expected to display different biological functions. The protein translated from this array of genes to serve as the foundation for building more complex structures and catalytic machinery that is the basis for metabolic, developmental and physiological processes complex organisms and life possible. The final location of these structures and their corresponding functional activity also determined the underlying gene sequences that code for their formation. New assessments of the human genome is estimated that the human genome contains approximately 140,000 genes. Although each of these sequences varied role, many of these genes can be grouped into classes based on the function of the proteins for which they encode. Instead, when a gene sequence is translated into a protein that appears to be linked to an important physiological way, it may be particularly relevant for diagnostic and therapeutic use. The recognition and functional characteristics of all of the genetic determinants of life are among the challenges in modern biology and medicine.

Our analysis of this patent is as follows:

Abt Holding Company’s patent US 7420044 B1 deals with Nucleic acid and protein homologs and uses thereof.
The present invention relates to the identification of novel nucleic acid molecules and the proteins encoded by these nucleic acid molecules, as well as their production for use as therapeutics, diagnostics and for research purposes.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.